Level Four Advisory Services’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
Other funds holding VRTX
Level Four Advisory Services's VRTX Position: Q2 2026 in Review
Level Four Advisory Services increased its Vertex Pharmaceuticals (VRTX) stake by 5.4% in Q2 2026, buying an estimated $226K and bringing the position to 10,034 shares worth $4.98M. The position accounts for 0.14% of the portfolio, ranked #180.
Level Four Advisory Services first reported a position in VRTX in Q2 2020 and has held it in 21 quarters since. 1,757 funds tracked by Wall St. Rank hold VRTX as of Q2 2026.
- Level Four Advisory Services held 10,034 shares of Vertex Pharmaceuticals worth $4.98M as of Q2 2026.
- Level Four Advisory Services bought 510 Vertex Pharmaceuticals shares in Q2 2026, an estimated $226K.
- Vertex Pharmaceuticals made up 0.14% of Level Four Advisory Services's portfolio in Q2 2026, its #180 holding.
- Level Four Advisory Services first reported a position in Vertex Pharmaceuticals in Q2 2020 and has held it in 21 quarters since.
- 1,757 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q2 2026.
Based on Level Four Advisory Services's 13F filing for Q2 2026, filed 10 Aug 2026.